Trophos SA - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Trophos SA - Product Pipeline Review - 2014" provides data on the Trophos SA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Trophos SA's corporate website, SEC filings, investor presentations and featured press releases, both from Trophos SA and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Trophos SA - Brief Trophos SA overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Trophos SA human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Trophos SA with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Trophos SA's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Trophos SA's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Trophos SA in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Trophos SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Trophos SA.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Trophos SA and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Trophos SA Snapshot 5
Trophos SA Overview 5
Key Information 5
Key Facts 5
Trophos SA - Research and Development Overview 6
Key Therapeutic Areas 6
Trophos SA - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Trophos SA - Pipeline Products Glance 10
Trophos SA - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Trophos SA - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Trophos SA - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Trophos SA - Drug Profiles 15
olesoxime 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
TRO-40303 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Small Molecules For Multiple Sclerosis 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecules For Parkinson's Disease 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecules for Huntingtons Disease 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Trophos SA - Pipeline Analysis 23
Trophos SA - Pipeline Products by Therapeutic Class 23
Trophos SA - Pipeline Products by Target 25
Trophos SA - Pipeline Products by Route of Administration 26
Trophos SA - Pipeline Products by Molecule Type 27
Trophos SA - Pipeline Products by Mechanism of Action 28
Trophos SA - Recent Pipeline Updates 29
Trophos SA - Dormant Projects 33
Trophos SA - Discontinued Pipeline Products 34
Discontinued Pipeline Product Profiles 34
olesoxime 34
Trophos SA - Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37

List of Tables
Trophos SA, Key Information 5
Trophos SA, Key Facts 5
Trophos SA - Pipeline by Indication, 2014 7
Trophos SA - Pipeline by Stage of Development, 2014 8
Trophos SA - Monotherapy Products in Pipeline, 2014 9
Trophos SA - Phase III, 2014 10
Trophos SA - Phase II, 2014 11
Trophos SA - Phase I, 2014 12
Trophos SA - Preclinical, 2014 13
Trophos SA - Discovery, 2014 14
Trophos SA - Pipeline by Therapeutic Class, 2014 24
Trophos SA - Pipeline by Target, 2014 25
Trophos SA - Pipeline by Route of Administration, 2014 26
Trophos SA - Pipeline by Molecule Type, 2014 27
Trophos SA - Pipeline Products by Mechanism of Action, 2014 28
Trophos SA - Recent Pipeline Updates, 2014 29
Trophos SA - Dormant Developmental Projects,2014 33
Trophos SA - Discontinued Pipeline Products, 2014 34